Company to view next
Generic selectors
Exact matches only
Search in title
Search in content

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase 1 clinical study for the treatment of non-Hodgkin’s lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors, including hepatocellular carcinoma, gastric cancer, and squamous cell carcinoma of the lung. The company is based in Boston, Massachusetts.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

81

Address:

Adicet Bio, Inc. 500 Boylston Street 13th Floor Boston MA 02116 United States

Website:

http://www.adicetbio.com

Phone:

857-315-5528

Leave a comment

Your email address will not be published. Required fields are marked *